CHI3L1 and hepatocellular carcinoma: Studies have found that the HCC patients with higher CHI3L1 had significantly lower rates of OS and disease-free survival (DFS) than those with lower levels of CHI3L1, suggesting that CHI3L1 is an independent predictor for survival in HCC patients 17,18.